Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy-Reference-Cited by-同舟云学术

Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy

Published:2016-09-01 Issue:9 Volume:73 Page:1070
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Wang Liang¹,Benzinger Tammie L.²,Su Yi³,Christensen Jon³,Friedrichsen Karl³,Aldea Patricia³,McConathy Jonathan⁴,Cairns Nigel J.¹,Fagan Anne M.⁵,Morris John C.⁵,Ances Beau M.⁶

Affiliation:

1. Department of Neurology, Washington University, St Louis, Missouri2The Charles F. and Joanne Knight Alzheimer’s Disease Research Center, Washington University, St Louis, Missouri

2. The Charles F. and Joanne Knight Alzheimer’s Disease Research Center, Washington University, St Louis, Missouri3Department of Radiology, Washington University, St Louis, Missouri

3. Department of Radiology, Washington University, St Louis, Missouri

4. Department of Radiology, University of Alabama, Birmingham

5. Department of Neurology, Washington University, St Louis, Missouri2The Charles F. and Joanne Knight Alzheimer’s Disease Research Center, Washington University, St Louis, Missouri5The Hope Center for Neurological Disorders at Washington University, St Louis, Missouri

6. Department of Neurology, Washington University, St Louis, Missouri2The Charles F. and Joanne Knight Alzheimer’s Disease Research Center, Washington University, St Louis, Missouri3Department of Radiology, Washington University, St Louis, Missouri5The Hope Center for Neurological Disorders at Washington University, St Louis, Missouri

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Cited by 254 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Prediction of Quercetin Analogs for Targeting Death-Associated Protein Kinase 1 (DAPK1) Against Alzheimer’s Disease;Current Neuropharmacology;2024-12

2. The memory binding test in a longitudinal study of cognitive aging and preclinical disease.;Neuropsychology;2024-09

3. Tau PET positivity predicts clinically relevant cognitive decline driven by Alzheimer’s disease compared to comorbid cases; proof of concept in the ADNI study;Molecular Psychiatry;2024-08-23

4. Visual Impairment, Eye Conditions, and Diagnoses of Neurodegeneration and Dementia;JAMA Network Open;2024-07-30

5. Differential effect of an evolving amyloid and tau pathology on brain phospholipids and bioactive lipid mediators in rat models of Alzheimer-like pathology;Journal of Neuroinflammation;2024-07-30